Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07268404 · ClinicalTrials.gov registry record · NA

Women's Hormonal and Metabolic Wellbeing Study

A NA study of Metabolic Health, sponsored by Daily Nouri.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07268404 is a NA study of Metabolic Health that is actively recruiting participants, run by Daily Nouri. The registered enrollment target is 60 participants, below the 50,139-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07268404, a NA study of Metabolic Health, is actively recruiting participants, sponsored by Daily Nouri.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if Daily Nouri Hormone Balance Probiotic blend can improve metabolic, inflammatory, and symptom outcomes in women. Participants will: * Take the probiotic blend or placebo every day for 12 weeks * Complete virtual assessments and report symptoms throughout the study

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Probiotic Blend Capsule

Study Locations (1)

California

  • Alethios, Inc. - San Francisco

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-12
Est. Completion 2026-12
Phase NA

Sponsor

Daily Nouri

1 total trials

What the Registry Record Tells You About NCT07268404

The ClinicalTrials.gov registry entry for NCT07268404 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 50,139-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The listed sponsor is Daily Nouri, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07268404 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07268404 about?

NCT07268404 is a clinical study titled "Women's Hormonal and Metabolic Wellbeing Study". The goal of this clinical trial is to learn if Daily Nouri Hormone Balance Probiotic blend can improve metabolic, inflammatory, and symptom outcomes in women. Participants will: * Take the probiotic blend or placebo every day for 12 weeks * Complete virtual assessments and report symptoms througho...

What is the current status of trial NCT07268404?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-12. Estimated completion is 2026-12.

What conditions does trial NCT07268404 study?

This clinical trial studies the following conditions: Metabolic Health.

What interventions are being tested in trial NCT07268404?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic Blend Capsule (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07268404?

This trial is sponsored by Daily Nouri, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07268404 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.